Pharmacokinetics of oral medications
Pro Research Analysisby 
Searched over 200M research papers
Key Concepts in Oral Medication Pharmacokinetics
Oral pharmacokinetics describes how drugs taken by mouth are absorbed, distributed, metabolized, and eliminated by the body. The process is influenced by both the properties of the drug and the physiological state of the patient, making prediction and control of drug exposure complex and variable 134.
Modeling Approaches for Oral Drug Pharmacokinetics
Compartmental and Empirical Models
Simple compartmental and empirical models are often used to describe oral drug absorption. These models divide the body into compartments and use mathematical equations to predict how drugs move between them. While straightforward, they may not capture all the complexities of oral absorption .
Physiologically Based Pharmacokinetic (PBPK) Models
PBPK models are more advanced and use detailed physiological and drug-specific data to simulate drug absorption, distribution, metabolism, and excretion. These models can integrate in vitro data and are especially useful for predicting how changes in physiology (such as disease or age) affect drug pharmacokinetics 39. PBPK models are also being explored to predict the impact of conditions like diarrheal diseases on oral drug absorption, though challenges remain in accurately modeling these effects .
Machine Learning and In Silico Approaches
Recent advances include the use of machine learning and in silico models, which combine computational predictions with laboratory data to improve the accuracy of pharmacokinetic predictions. Incorporating variables like intrinsic clearance, plasma protein binding, and solubility into these models has been shown to significantly improve prediction accuracy for oral drug exposure .
Factors Affecting Oral Drug Absorption and Variability
Physiological and Population Variability
Oral drug absorption is highly variable due to differences in gastrointestinal physiology, age, disease states, and even surgical changes in anatomy. Factors such as gastric pH, gastric emptying time, intestinal fluid properties, and the presence of food can all impact how much and how quickly a drug is absorbed . Special populations, such as pediatric or elderly patients, may experience different pharmacokinetics due to these physiological differences .
Disease States
Conditions like heart failure can alter the pharmacokinetics of oral medications, especially in patients with more severe or decompensated disease. For some drugs, systemic exposure can increase significantly in these patients, particularly if there is concurrent liver or kidney dysfunction . Diarrheal diseases can also impact drug absorption by altering gut physiology, potentially leading to suboptimal drug exposure .
Drug-Drug and Food-Drug Interactions
Oral medications can interact with other drugs or food, affecting their absorption and metabolism. For example, drugs that alter stomach pH can impact the absorption of certain anticancer medications, and enzyme inhibitors or inducers can change how drugs are metabolized . Glucagon-like peptide 1 receptor agonists (GLP1RAs), used in diabetes, can slow gastric emptying and delay the absorption of co-administered oral drugs, but these changes are generally not clinically significant for most medications .
Special Considerations for Complex Molecules
Some orally administered compounds, such as polysaccharides from traditional Chinese medicines, have poor systemic absorption but can still exert significant local and systemic effects by interacting with the gut microbiome and immune system. Improving the oral bioavailability of such compounds and understanding their pharmacokinetic interactions with other drugs are important areas for future research .
Conclusion
The pharmacokinetics of oral medications are influenced by a complex interplay of drug properties, patient physiology, disease states, and interactions with other substances. Advances in modeling, including PBPK and machine learning approaches, are improving our ability to predict and understand these processes. However, significant variability remains, and careful consideration is needed when prescribing oral medications, especially in special populations or in the presence of disease or drug interactions 1345+4 MORE.
Sources and full results
Most relevant research papers on this topic
Prediction of Oral Pharmacokinetics Using a Combination of In Silico Descriptors and In Vitro ADME Properties.
Combining in silico and in vitro parameters improves the predictivity of oral pharmacokinetics in rats, supporting potential applications in human and other non-clinical species.
Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models
Oral physiologically-based pharmacokinetic (PBPK) models can effectively predict drug absorption in the human body, aiding in drug development and pharmaceutical industry applications.
Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: an UNGAP review.
Gastrointestinal tract variability, including gastric pH, emptying time, and small intestinal fluid properties, influences oral drug absorption, with formulation approaches during drug development potentially reducing this variability.
DOI